Incyte is collaborating with Actuate Therapeutics and researchers at the University of Pittsburgh on a clinical trial targeting advanced pancreatic cancer.
1 report, 1 independent
Updated Aug 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Incyte is collaborating with Actuate Therapeutics and researchers at the University of Pittsburgh on a clinical trial targeting advanced pancreatic cancer.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Coverage
Newest first; wire copies grouped- GlobeNewswireActuate Therapeutics To Collaborate with Incyte Corporation and the University of Pittsburgh on Clinical Trial of Elraglusib in Combination with Retifanlimab and mFOLFIRINOX in Patients with Advanced